CDH1 and breast carcinoma: Three (2.5%) in BRCA1, nine (7.5%) in BRCA2, two (1.7%) each in MUTYH, CHEK and PALB2, one (0.8%) each in ATM, BARD1, NBN, RAD51C, TP53 were identified in the breast cancer group, while seven (5.8%) in MUTYH, three (2.5%) in ATM, two (1.7%) in BRCA2, one (0.8%) each in BARD1, BRIP1 and CDH1 were identified in the high-risk group.